Aberrant Promoter Hypermethylation Inhibits RGMA Expression and Contributes to Tumor Progression in Breast Cancer

The authors found that RGMA was downregulated in breast cancer (BC) tissues compared with non-tumorous breast tissues, particularly in metastatic BC samples, and that patients with low RGMA expression manifested a poorer prognosis.